Emprint™ ablation systems

Using our patented Thermosphere™ technology, the Emprint™ HP ablation generator enables a minimally invasive procedure with:

• Large ablations, with up 40% more volume compared to the original Emprint™ ablation system¹
• Proven spherical shape,^2-8 giving you flexibility in antenna placement approach⁹
• Consistent ablative margins greater than 5mm^9,†
• Scalability, allowing you to create both small and large ablation zones¹

Listen to Prof. Vogl describe his experience with microwave ablation.

Ex-vivo tissue comparison video

Technical support

Customer technical helpline: 01452 223217
Email: rs.gi-support@medtronic.com

A dedicated support center for the solutions of technical issues

• Customer technical service center for gastrointestinal and hepatology products.

References

† Independent study was performed using the 100 W Emprint™ ablation generator. A total of 56 tumors ablated with the Emprint™ ablation system had a median size of 1.4 cm (range 0.4 to 3.7 cm).

1. Versus the Emprint™ ablation generator. Based on internal testing data RE00205202 Emprint™ Performance Report, dated Jan 2020.

2. Imajo K, Tomeno W, Kanezaki M, et al. New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones. J Gastroenterol Hepatol. 2018;33(12):2007–2014.

3. Zaidi N, Okoh A, Yigitbas H, et al. Laparoscopic microwave thermosphere ablation of malignant liver tumors: An analysis of 53 cases. J Surg Oncol. 2016;113(2):130–134.

4. Based on internal testing report R0043973, In vivo performance testing of the Emprint™ microwave ablation system in a porcine model. March 2014.

5. Based on internal testing report R0054596, Emprint™ MWA System with CT Imaging in a porcine model. April 2016.

6. Howk K L C, Peterson D, Cafaro A. Consistent and predictable spherical ablation shape in both liver and lung: performance of the Emprint™ ablation system with Thermosphere™ technology in an in vivo porcine model [Poster 129]. Journal of Vascular. 2015.

7. Ierardi AM, Mangano A, Floridi C, et al. A new system of microwave ablation at 2450 MHz: preliminary experience. Updates Surg. 2015;67(1):39–45.

8. De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.

9. Vogl TJ, Basten LM, Nour-Eldin A, et al. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. Int J Hyperthermia. 2018;34(4):492–500.

10. Ruers T, Van Coevorden F, Punt CJA, et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.

11. Drake TM, Harrison EM. Malignant liver tumours. Surgery. 2017;35(12):707–714.

12. De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.

13. Takahashi H et al. Local Recurrence After Microwave Thermosphere Ablation of Malignant Liver Tumors: Results of a Surgical Series. Surgery 2018 Apr;163(4):709-713.

14. Based on internal test report #RE00085432, An acute GLP study to evaluate the performance and safety of the Emprint SX ablation platform in a porcine model. 2017